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Abstract
Background: Prehospital ambulance based research has unique ethical considerations due to urgency, time
limitations and the locations involved. We sought to explore these issues through interviews with experts in this
research field.
Methods: We undertook semi-structured interviews with expert informants, primarily based in the UK, seeking their
views and experiences of ethics in ambulance based clinical research. Participants were questioned regarding their
experiences of ambulance based research, their opinions on current regulations and guidelines, and views about
their general ethical considerations. Participants were chosen because they were actively involved in, or in their
expert capacity (e.g. law) expressed an interest in, ambulance based research.
Results: Fourteen participants were interviewed including principal investigators, researchers, ethicists and medical
lawyers. Five major themes were identified: Capacity, Consent, Clinical Considerations, Consultation and Regulation.
Questions regarding consent and capacity were foremost in the discussions as all participants highlighted these as
areas for concern. The challenges and use of multiple consent models reflected the complexity of research in this
environment. The clinical theme referred to the role of paramedics in research and how research involving
ambulance services is increasingly informing improvements to patient care and outcomes and reducing the burden
on hospital services. Most felt that, although current regulations were fit for purpose, more specific guidance on
implementing these in the ambulance setting would be beneficial. This related closely to the theme of
consultation, which examined the key role of ethics committees and other regulatory bodies, as well as public
engagement.
Conclusions: By interviewing experts in research or ethics in this setting we were able to identify key concerns and
highlight areas for future development such as improved guidance.
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Background
Trials involving ambulance services are a rapidly devel-
oping field, with increasing numbers and scale of studies
globally. Early intervention, for example in myocardial
infarction, stroke or cardiac arrest, could significantly
improve patient outcomes, but needs to be tested in situ,
as existing treatments administered in this context are
often either unsatisfactory [1–3] or lack an evidence base
[4, 5]. In the UK the types of research undertaken within
the ambulance service include drugs trials, device trials
and investigations into alternative care pathways. These
trials can be complex and several papers identify the
unique challenges of prehospital research, both ethical
and practical [6–8]. This study sought to identify these
challenges in depth with a range of expert stakeholders.
A systematic review of prehospital trials highlighted
capacity and consent as being particularly challenging
[9]. Patients in the prehospital setting are often incap-
able of giving consent and are therefore a vulnerable
population [3, 10–12]. Even if not unconscious, patients
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may be in too much pain or be too distressed and over-
whelmed by the situation to give the question of consent
due consideration [8, 11, 13]. Ambulance-based research
also differs from other emergency research settings due
to the unpredictability of the location. Incidents could
occur in public spaces, patients’ homes or the ambulance
itself, for example, all of which might inhibit a patient’s
ability to engage with a consent process. Furthermore,
time pressures mean that lengthy processes for assessing
capacity could be impracticable [8]. Increasingly studies
seek to proceed without consent when consent processes
would delay an intervention to the extent that it would
no longer replicate practice, or when delayed treatment
might cause additional stress or harm [1, 11, 14–17].
Due to the complexity of the setting, alternative con-
sent models have been proposed [9]. Surrogate or proxy
consent is a common approach whereby the surrogate is
asked to act in the ‘best interests’ of the patient [8, 11,
18]. Most often the surrogate will be a relative or close
personal friend, but there are provisions that allow a
medical professional to act as a proxy. Previously, it has
been questioned whether a paramedic or emergency
medical technician (EMT) can fulfil this role [17]. An-
other common option is emergency waiver of consent
(sometimes termed ‘delayed consent’ or ‘deferred con-
sent’) [9]. In this model patients are given the interven-
tion without prior consent, and later approached to give
consent for ongoing participation and use of data [14].
This is particularly relevant where timeliness of treat-
ment may render it impossible to seek surrogate consent
[4, 12, 16, 19]. Studies in both the US and UK found
that, whilst most patients felt this form of enrolment
was acceptable, some expressed concern over the loss of
autonomy that deferred consent entails [15, 20].
In England and Wales clinical research is governed by
two pieces of legislation. The Medicine for Human Use
(Clinical Trials) Regulation (2004) (MHU-CT) must be
adhered to in clinical trials of investigational medicinal
products (CTIMP) [21]. The Mental Capacity Act (2005)
(MCA) applies to all other research, including trials
using non-medicinal interventions such as devices or
non-interventional studies [22]. Both pieces of legislation
give guidance regarding the enrolment of participants on
to trials and in particular those who lack capacity to
consent [23]. Ambiguity regarding the correct applica-
tion of the legislation, especially with regards to partici-
pants who have reduced capacity, can be challenging
and has been highlighted as an aspect in need of clarifi-
cation in prehospital research [16].
The complexity of enrolling patients into research in
the prehospital setting notwithstanding, it should be re-
membered that consent is not the only ethical consider-
ation. Paramedics’ traditional priorities of getting
patients to hospital as soon as possible whilst providing
optimal care may not easily align with research [6, 24–
26]. A questionnaire study with UK paramedics found
that lack of time, support and opportunities for research
also prevented participation [24]. Stronger engagement
by prehospital researchers with not only paramedics [6],
but also research ethics committees [10, 16] and affected
communities [27], can help to foster acceptance of
emergency research.
This project sought the views of experts in the field of
prehospital ambulance based research, in order to
understand the ethical considerations and pressures
faced by researches currently working in this setting.
Throughout this paper we use the generic term trial(s),
except where it is appropriate to specify the type of re-
search undertaken.
Method
Participant recruitment
Participants were recruited using a purposeful snowball
sampling technique, which allowed us to reach a range
of participants through existing contacts. Since we
wanted to gain the views of people who had experience
in undertaking ambulance based research, we specifically
targeted participants who were leading or actively in-
volved in ambulance trials or medical ethics research on
emergency or ambulance studies. The initial participants
were those who had previously expressed an interest in
the ethics of ambulance based trials at a networking
event on 1st March, 2016 (Newcastle, UK). Additional
participants were identified through recommendations
made during the interviews or through contacts at sub-
sequent conferences and meetings. Participants were
provided with a participant information sheet and con-
sent form and written consent was gained prior to
participation.
Data collection and analysis
The interviews continued until data saturation was
attained [28]. Data were collected through semi-
structure interviews either via the telephone or Skype
and were digitally recorded. Skype interviews were of-
fered in the first instance, as these have the advantage of
both face-to-face interviews, in terms of interaction with
the participant, and telephone interviews in terms of
convenience and cost savings. The interviews lasted be-
tween 25 and 50min. Approximately half of the inter-
views were carried out using Skype. Telephone
interviews were recorded using a digital Dictaphone
whilst Skype interviews were recorded using Audacity
software (Free Software Foundation, Boston, USA). Au-
dacity only records audio from the interview, and files
are saved in the same digital format as the Dictaphone
files. All recordings were transcribed verbatim as soon as
possible after the interview and the digital recordings
Armstrong et al. BMC Medical Ethics           (2019) 20:88 Page 2 of 12
immediately deleted. Participants were asked about their
experiences of prehospital trials, the ethical consider-
ations, barriers and facilitators in such trials and consent
processes.
The transcriptions were analysed thematically using
NVivo 10 and coded independently by two authors (SA
and AL). The initial list of codes were agreed through
discussions between the coders. These codes were then
compared and grouped into higher order themes
through discussions within the team (SA, AL and ANS).
Findings
Fourteen participants were interviewed, 13 based in the
UK and one in Sweden. Table 1 lists the participants
identifying number alongside their role/research experi-
ence. Most of the participants had academic roles, prin-
cipal researchers generally holding professorial titles,
whilst the ethicists and the medical lawyer were also in
academic research positions. The research paramedics
and research nurse were all in clinical positions with
additional research responsibilities.
The thematic analysis of the transcriptions resulted in
five major themes being identified. These were: capacity,
consent, clinical considerations, consultation and regula-
tion. A sixth theme of ethical complexity was pervasive
across these five themes.
Understanding capacity to consent to research (capacity)
The first theme addresses physical and mental capacity
and the ability of patients in the ambulance setting to
make informed choices. Throughout all the interviews it
was apparent that mental capacity was an important eth-
ical consideration in both the design and implementa-
tion of ambulance based research. Discussion regarding
capacity centred on whether someone who calls an am-
bulance has the mental capacity to make an informed
choice, specifically regarding participation in a trial, even
if conscious (EX02, EX03, EX04, EX11, EX12). For ex-
ample, a prehospital research fellow commented:
Fundamentally I just question this whole concept of
consent under those situations for research. I just
don’t think it really exists and that the nearest you
can get to somebody’s individual consent in those
particular circumstances is probably a gut feeling
from them. Or a gut feeling from their family about
whether they would generally speaking want to take
part in research or not. [EX03].
And speaking particularly about stroke, a research
nurse raised the issue of both mental and physical
capacity:
I would strongly question whether anybody who is
having a stroke or has had a stroke can make any sort
of informed consent decision … ..but then I suppose if
you are having a stroke as well it’s how you convey
that you can understand that information, if your
speech is already gone. [EX12].
Assessment of capacity was also a factor. Several par-
ticipants discussed whether it was possible to assess cap-
acity in the ambulance (EX04, EX07, EX08, EX09, EX11,
EX12). One principal researcher suggested the following
protocol:
To determine capacity in the ambulance, which was
basically telling the patient what their condition was,
i.e. stroke, a particular issue which was relevant to
them, which was their blood pressure was higher than
ideal and the intervention which was a skin patch,
which might lower blood pressure. And we then asked
them, “What do we think’s wrong with you?” And
they were obviously meant to say stroke. And “What’s
particularly the issue right now?” – “I’ve got high
blood pressure”. “And what do we want to do about
it?” – “You wanna put a patch on”. And if they could
get those 3 ideas, and relay them back to us then we
assumed they had capacity. [EX09].
But others countered this by saying that in their ex-
perience, even if the patient was able to answer ques-
tions at the time, thereby giving consent, they often did
not retain this information, even a short time later
(EX04, EX07).
Finally, related to this theme were questions about
whether the emergency setting may mean that people
may be too distressed to really take in the information
Table 1 List of participants job roles
Code Experience
EX01 Prehospital principal researcher
EX02 Prehospital principal researcher
EX03 Prehospital research fellow
EX04 Prehospital principal researcher
EX05 Ethicist
EX06 Research paramedic
EX07 Emergency Department researcher
EX08 Prehospital principal researcher
EX09 Prehospital principal researcher
EX10 Research paramedic
EX11 Ethicist
EX12 Emergency Department research nurse
EX13 Prehospital principal researcher
EX14 Medical lawyer
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given to them, or may agree to something when they
might not have done had they had more time to con-
sider it (EX03, EX06, EX08, EX10, EX11, EX12). A para-
medic voiced their doubts as follows:
… their whole world can change within 10 min. So if
you’re now trying to reassure them, address their
problems and now you are going to approach them
about a research project that actually they need to
fully understand the information, the risks, the
benefits. Are they necessarily in the right frame of
mind to do that? [EX10].
And an ethicist commented:
And the third criterion is lack of voluntariness or lack
of coercion. And you could argue that that criterion
can’t be met in this context, because they are having
an emergency event, so they are going to do whatever
the hell you suggest. [EX11].
This theme raised questions regarding what consti-
tutes capacity in the out-of-hospital emergency setting,
the different mental and physical barriers to capacity
and how to assess these in the necessarily short time
period of the event. These are crucial factors on deter-
mining appropriate consent models in ambulance based
research.
Models of consent (consent)
The consent theme contained the largest number of in-
dividual codes and covers all aspects of consent in the
ambulance research setting. This was the area that gen-
erated most discussion, with a wide range of views
expressed regarding best practice for gaining consent in
ambulance trials. All participants agreed that consent in
this setting is complex, particularly in light of the previ-
ous discussions regarding capacity. Participants from
across a range of roles agreed that gaining prior written
informed consent in the ambulance could be problem-
atic (EX05, EX07, EX08, EX10, EX12), and therefore dis-
cussion tended to centre on consent methods that could
be used where there was a lack of capacity.
Within both the MHU-CT and the MCA there are
provisions that allow participants who are unable to give
consent and have no surrogate present to be entered
into an emergency trial. Participants discussing these
provisions often used the terms ‘waived’ or ‘deferred
consent’ (EX09, EX10, EX12). For example:
I know that a number of trials are using waiver of
consent. I think this absolutely has a place, and
certainly where those trials are recruiting patients that
cannot consent, they are unconscious, they are in
cardiac arrest, there is no consent that can be gained
[in] the environment in which they are in the clinical
care that they need to provide is timely. [EX10].
Waived or deferred consent usually involves a process
whereby consent is gained after the emergency has
passed (EX05, EX08, EX14). This generally gives the par-
ticipant (or their representative if they are unconscious
[EX08]) the opportunity to withdraw from any further
participation in the study or to agree to data use and fol-
low up data collection (EX04, EX09, EX12, EX13):
….so for all of the patients that are enrolled in the
emergency situation in A&E we then pursue them
and their families throughout their hospital stay and
the kind of end goal is to get an informed choice
decision, whether that’s to stay in the trial or to leave
the trial, from the patient themselves. So that can
sometimes be 28 days later, or never if unfortunately
they die. [EX12].
Proxy or surrogate consent was also discussed in detail
in all the interviews. The use of relatives as surrogates,
where available, was most common and this was felt to
be an acceptable form of consent should a patient be in-
capacitated. Additionally, some participants discussed
whether close friends or work colleagues could act as
surrogates (EX05, EX06, EX09, EX11), with one ques-
tioning how well a work colleague might know a patient
and how to assess this (EX12). The rationale for asking a
relative to consent on an incapacitated patient’s behalf is
that “it’s the closest that we can get to knowing what the
patient’s wishes would have been” (EX03). A principal
researcher articulated this thus:
I think that approach that we used is to use a family
member as somebody to give consent on behalf of the
patient if they don’t have capacity at the time, or at
least to give short consent. I think that’s the most
appropriate approach for the research that I’ve been
involved in. [EX02].
A number of participants did express some concerns,
regarding whether a relative can accurately represent a
patient’s wishes. One said, for example:
I’ve had family members who’ve asked for the
patients to be withdrawn from the trial and then
when I’ve later gone back and spoken to the
patient they’ve said, “Ah no I would’ve stayed in, I
would have done it.”… And I’ve had relatives trying
to persuade patients to take part in research as
well, which is the other way round, which is what
you don’t want as well. [EX12].
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Others agreed that, like patients, potential surrogates
can find the emergency too stressful an environment in
which to make decisions (EX01, EX06, EX10, EX11:
I think having been out in clinical practice
resuscitating people in their houses and in the street
and things with family members being very distressed
around, that’s not the time to try and have that
conversation. [EX01].
Finally, some questioned whether anyone but the pa-
tient can give ‘consent’ (EX03, EX04). At most, they felt
a surrogate could give an opinion (on the patient’s phil-
osophy on health research, for example), rather than
consent per se. This is where ambiguity over termin-
ology was apparent in some of the discussions, with sev-
eral participants using a blanket term of ‘consent’. Note
that the MCA uses the language of consultation rather
than consent, as surrogates are referred to as ‘consul-
tees’, whereas the MHU-CT allows informed consent by
a legal representative.
Under the MHU-CT regulations, if a relative is un-
available, the patient’s doctor or a person nominated by
the relevant healthcare provider can be a legal represen-
tative and thus able to provide consent, provided they
are unconnected with the trial. The use of this type of
surrogate was discussed intensely, particularly with
regards to paramedics taking this role. One principal re-
searcher described the use of this consent model in a re-
cent CTIMP as “ground breaking in several ways” and
“well received by the scientific community” (EX09),
whilst a paramedic thought it was acceptable, with the
caveat that “the patient or their representatives must al-
ways be given consideration and the option to withdraw
from the study further down the line” (EX06). Other
participants had reservations. The arguments against
using paramedics as legal representatives fell into two
groups. Firstly, some questioned whether a paramedic
was independent of the research (EX01, EX05, EX11,
EX13 EX14). For example, one ethicist said:
A nominated legal representative must be an
independent doctor or I think – if I remember
correctly a person appointed by the trust or health
authority for that purpose. So I’ve never been quite
sure about who that other person might be, but
what it is really saying is that it should be an
independent doctor. So I would read from that that
a paramedic couldn’t take on the role of the
nominated legal representative in a clinical trial.
[EX05].
Secondly, others felt that it placed undue responsibility
on the paramedic during the emergency situation (EX01,
EX04, EX08, EX12, EX13). For example, one principal
researcher expressed their doubts as follows:
I think it’s placing a lot of emphasis and responsibility
onto the paramedic in making that decision and in
making that decision when they are highly unlikely to
have ever met the patient before or have any basis
upon which to make, to form that judgement. [EX13].
Due to the complexity of obtaining written consent in
ambulance based trials, even from surrogates, other
models were discussed. The first was to gain affirmation
from the patient that they were happy to proceed. This
was termed variously ‘assent’ or ‘short consent’. This
model suggests that patients may not be able to give
written informed consent because of time pressures or
distress, but may be able to consent to the intervention
or treatment, and thereby assent to being in the trial
(EX02, EX06, EX08, EX10, EX11, EX13). The model can
also be used for relatives acting as surrogates (EX03,
EX12). The assent would later be confirmed by gaining
written consent once the emergency had passed:
We do an oral informed consent first, so the patient
gets a very short information about the trial, basically
asking, “We are looking at this, are you willing to
participate?” And then during the first 24 h of the
hospital stay they get a more thorough written
informed consent form to read and then to sign.
[EX07].
Across the expert roles (EX03, EX04, EX05,1 EX06,
EX13), participants believed that the advantage of this
model is that it is workable in the emergency context.
For example, one principal researcher commented:
So I think initial assent does make a lot of sense. …I
think it better reflects the cognitive capacity of the
patients at that particular time. And so I think that
model is worthy of exploration but it is not one that is
widely recognised. [EX04].
Whilst, a paramedic said:
So I think that is a good workable model and does
give the patient some input – into their treatment
and, given the opportunity, whether they would want
to be involved. [EX06].
The final model, discussed in some detail, was the idea
of ‘opt out’, whereby potential participants receive
1This participant, however, did advise against the use of the term
‘assent’ to describe this process, as it does not appear in UK legislation.
Armstrong et al. BMC Medical Ethics           (2019) 20:88 Page 5 of 12
information prior to the study and are able to opt out of
participation by wearing a bracelet or other identifica-
tion that paramedics must check for. On the whole,
those who discussed this option felt that the burden on
trials were too great, in terms of both costs and time, to
ensure that members of the public had adequate oppor-
tunity to opt out (EX02, EX11, EX13).
Furthermore, one researcher described how studies
that had used an opt-out system had been “slaughtered”
when they presented their data, as the principle of expli-
cit patient consent is so ingrained (EX07).
This theme highlighted that the general challenges to
giving consent for trials can be compounded by the am-
bulance setting. Whilst multiple models for gaining con-
sent exist, it is not always clear when each should be
applied.
Clinical staff involvement in ambulance research (clinical)
The clinical theme refers to the use of paramedics in tri-
als, and how involvement in ambulance based research
informs paramedics’ professional competencies, as well
as expectations around patient care. The theme is con-
cerned with what the practical barriers to implementa-
tion of ethical research in this clinical environment
might be. Some participants discussed the relative new-
ness of research in this setting, and the need to ensure
that paramedics understand the purpose and processes
of research and research ethics. Several participants
highlighted the need for general research training for all
paramedics, including consent procedures (EX01, EX03,
EX04, EX09, EX12).
So there are real training issues and that’s a real
barrier and of course that’s relevant to your project
on, on ethics and, and consent and so on because we
must make sure these people understand the ethics of
the study, the consent process. So how do we train
people is, is a major issue. [EX09].
Perceptions of paramedics’ attitudes to both research
and training differed. One prehospital researcher had en-
countered reluctance on the part of paramedics to en-
gage in research:
There are a significant minority of paramedics who
simply don’t want to do research. The worst thing in
research is to force people ‘cause they simply don’t do
it. You can train them all and they won’t do it. They’ll
always have a reason why they didn’t do it, so it’s just
a waste of time and effort and it stresses them and so
on. [EX09].
Others had found paramedics to be enthusiastic about
research:
The paramedics were happy to be trained, they were
happy to take on that extra responsibility… We’ve had
very few paramedics refuse to help with the study.
[EX03].
So I think from paramedics we’ve met a lot of
enthusiasm and support for important research
questions. [EX13].
The two research paramedics noted that paramedics
can be unfamiliar with the research context and ethical
approval procedures, as well as uncertain about whether
research is in patients’ best interests:
Assessing the capacity of that participant or
potential participant could be quite daunting the
first time you come to do it. And without any sort
of research experience that can be quite difficult.
[EX10].
Is it ethical to involve people in trials if it delays their
treatment is one of the big questions that we get
asked. [EX06].
Yet they and others (EX03, EX04, EX09) recognised
that the research culture within ambulance services is
already showing signs of change, as more paramedics are
now trained at degree level and thus “exposed to re-
search, exposed to evidence based medicine from day
one” (EX06). Prehospital research would thus be “miss-
ing a trick” if it did not use paramedics (EX10).
Despite these changes, the challenges of developing a
research culture in a relatively research-naïve organisa-
tion (i.e. the ambulance service), and the difficulties of
disseminating information throughout this organisation,
were also raised:
I think whilst there has been such a wealth of
research that’s been done so far it’s, it, there’s
always been difficulty in disseminating that out to
staff members. And if you go and talk to a
standard road paramedic about what research is
going on, if they don’t actively have that interest, I
think the communication and the spread of the
knowledge hasn’t really reached its full potential.
[EX10].
In this regard, peer education and engaging para-
medics in the development of an intervention have
proved invaluable in fostering ownership of research
among paramedics (EX01, EX03).
The future of ambulance based trials and the need for
ambulance organisations to prioritise research, were also
discussed by both principal researchers (EX01, EX04)
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and the two research paramedics (EX06, EX10). For
example:
I think we need to get better at actually integrating
research and making [it] an organisational priority.
Most ambulance services are really building their
research teams and the level of research that’s going
on is developing all the time. But I think there’s some
work we can do with staff on the ground who are now
equipped with the research skills – let’s use them a bit
more and involve them. [EX10].
In general, it was felt that, whilst barriers to research
in ambulance services exist, especially in the form of or-
ganisational priorities and continued research naïvety,
ambulance research was expanding and would provide
some of the next advances in health care, as summarised
by one participant:
In the context of stroke the ambulance prehospital
environment is the next great clinical laboratory for
doing this sort of research. [EX09].
Consultation with ethics committees and public
involvement (consultation)
Lack of experience of ambulance based trials was also
evident in the consultation theme, which deals mainly
with ethical review and the role of ethics committees
in research, alongside wider consultation. There was
extensive discussion by participants regarding the role
of ethics committees. UK-based principal researchers,
paramedics, and ethicists alike felt that ethics com-
mittees varied widely in their understanding of the
ethical issues related specifically to ambulance trials,
particularly in terms of the unique consent consider-
ations and patient environment, which led to incon-
sistent responses to applications for ethical approval
(EX01, EX04, EX05, EX06, EX08, EX10). Two princi-
pal researchers said:
The ethics committees within the UK are very
variable in their response to this kind of problem.
Some of them are well informed and helpful and
sometimes they are so well informed in fact they are
quite positive around research without consent.
Sometimes they are extremely unhelpful. [EX04]
...and the inconsistency of decisions that you get from
them. So both from the ethics committees and from
individual participating research sites. They can end
up completely tied in knots And it changes from trial
to trial, from ethics committee to ethics committee,
from site to site. [EX08].
There has been similar inconsistency in Sweden, where
some ethics committees have approved oral assent
followed by later written consent, whilst others have
insisted on prior written consent. There is also “a lot of
responsibility if something goes wrong” for an ethics
committee, which may lead to caution over opt-out tri-
als, for example (EX07). The variability in the UK was
put down to the newness of the field by one paramedic:
Prehospital research is very new to ethics committees
and most ethics committees may not have people with
any experience or knowledge of prehospital studies.
[EX06].
Thus ways forward may include setting up specialist
committees and specific guidance and training for com-
mittees (EX02, EX04, EX06, EX08).
Where this has already happened through the National
Research Ethics Service (NRES),2 this has “made life eas-
ier all round and more efficient because you had a body
of people round specialist ethics committees who under-
stood the regulations and were used to dealing with the
complexity of these very vulnerable patients” (EX01).
According to the two paramedics (EX06, EX10), an-
other option is to invite those with prehospital research
experience on to existing ethics committees:
Including somebody on the ethics committee with
prehospital background, experience, knowledge,
dedicated insight into that realm, really that could
actually provide that specialist knowledge for the
types of trials that we’re going to be doing. [EX10].
In terms of wider consultation, patient and public in-
volvement is increasingly seen as an essential part of the
research process, from inception to completion, as one
principal researcher attested:
I think public consultation is important. It’s not a
requirement of the current legislation that there is
public consultation, but I think it’s a marker [of]
best practice. And certainly, any NIHR [National
Institute for Health Research] funded study would
expect, pretty intensive patient involvement. I think
it’s right to do so, it’s just I don’t think it’s
mandated to do so. [EX13].
They described some of their experiences with such
consultations. At a meeting with around 300 people in
attendance, about 80–90% were in favour of the waived
2The National Research Ethics Service (NRES) has been replaced and
is currently a core function of the Health Research Authority (HRA) in
the UK.
Armstrong et al. BMC Medical Ethics           (2019) 20:88 Page 7 of 12
consent model being proposed, but more people sup-
ported the research in general terms than said they
would be willing to enrol in the trial should they suffer
the condition under investigation.3 Overall, this re-
searcher saw sharing information with the wider com-
munity as a facilitator of research, but barriers included
mistrust of the government and the medical profession
(EX13).
Other principal researchers also outlined their experi-
ences. One (EX01) stated, “Obviously we have patient
and public engagement in the development of these
studies and consideration of the ethical aspects”. They
described how, on one trial, the ethics committee re-
quired the wider public to be informed, so materials
were translated into “a whole host of languages” and dis-
seminated via the trial website. It was important that the
public had as much information as possible before the
point of recruitment, “because at the point of recruit-
ment it doesn’t work because the patient is unconscious
and the family are very distressed”. There was also in-
depth consultation with a smaller group (5–20 people),
comprised of patient representatives (former patients or
their partners or children) and “so people who would be
even more objective who haven’t actually had exposure
to the condition and things and bringing a different view
point”. Another (EX02) related how a Patient and Public
Involvement (PPI) group on one trial had insisted that
the decision they were making was particular to that trial
“and that they didn’t want that to be a precedent for all
prehospital studies”. They also advocated public consult-
ation beyond PPI.
This theme dealt with the impact of ethics committees
and public consultation on prehospital research. Several
participants reiterated the importance of guidance, train-
ing and engagement with ethics committees and the
public more broadly to facilitate understanding of the
need for ambulance based research and the ethical con-
siderations involved.
Regulation within the United Kingdom (regulation)
The regulation theme concerns current legislation gov-
erning research in the UK, including the Medicines for
Human Use (Clinical Trials) Regulations (2004) and the
Mental Capacity Act (2005).4 Participants largely agreed
that legislation was fit for purpose, although some
commented on the challenge of getting to this position
(EX04, EX05, EX09):
And so the challenge has been to find mechanisms
and to lobby relevant legislative and regulatory bodies
to accept the need to try research in incapacitated
individuals and to support that research effectively.
[EX04].
The UK is perhaps more advanced than some other
countries in this respect. In Sweden, for example, emer-
gency research is more restricted legally:
The situation in Sweden is like this, that by law you
have to ask a patient to participate. If the patient
cannot answer, does not understand what you are
saying or is too sick to answer, then in principle the
patient is not allowed to participate in a trial. That’s
obviously a big problem for acute studies. [EX07].
Although some Swedish studies have now been
allowed to use waived consent, others have not been
allowed to enrol unconscious people (EX07).
Whilst the UK legislation was considered adequate,
several participants reported that there was often lack of
knowledge or confusion over the application of the regu-
lations, even among regulatory agencies (EX01, EX03,
EX05, EX08, EX10). Waiver of consent under both the
MHU-CT and the MCA must be approved by an NHS
(National Health Service) Research Ethics Committee,
who have determined that the investigative treatment
would be in the patient’s best interest and unlikely to
cause harm. Two principal prehospital researchers
commented:
I think the amendment in 2006 to the Medicines for
Human Use (Clinical Trials) Regulations was very
welcome.5 … What was unhelpful was the ethics
committees didn’t seem to know about those
regulations, that statutory instrument. And still a lot
of people don’t know about it. I think if you don’t
work in this particular world you won’t necessarily
know that those regulations exist. [EX01].
Our ethics committee had just said it was ethical but
we would need information governance approval. And
the information governance people said “No this is
not ethical”. [EX08].3They illustrated this point as follows: “It’s a little bit like organ
donation, you can be generally supportive of the concept but you don’t
like to face the idea on an individual basis because you are then
looking your own mortality in the face as it were” (EX13).
4Note that the Mental Capacity Act (2005) applies to England and
Wales. The equivalent legislation in Scotland is the Adults with
Incapacity (Scotland) Act (2000). The clinical trials regulations apply
to the whole of the UK.
5The amendment to the Medicines for Human Use (Clinical Trials)
Regulations 2006 allows participants who lack capacity and where a
legal representative is unavailable to be enrolled on to a the trial
without consent, where the Research Ethics Committee has approved
this method of enrolment.
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All participants highlighted the need for clear, specific
guidance regarding ambulance based research. This
would be useful in and of itself, but also to help prehos-
pital researchers in justifying their research plans:
Because it is such a new field, any sort of well-
founded guidance would be gratefully received by
most people and would give those working in prehos-
pital research something to work to and to support
their claims. [EX06].
One principal researcher suggested a comprehensive
framework that covered a range of scenarios, as current
guidance tends to focus on particular trial types (with
unconscious patients, for example), which does not work
when applied to other trial types:
I think that we have [to] work with the legislation
that’s there, but I think there are lots of nuances that
… require guidance. … And if we had some
comprehensive guidance which covers the various
eventualities and the various scenarios that the ethics
committees and the information/R&D governance
people could refer to we might waste much less time.
[EX08].
They went on to say that writing useful and accessible
guidance is not enough, as it then needs to be imple-
mented (EX08). Adoption might be facilitated by ensur-
ing wide consultation on any guideline revisions, to
include ethics committees, researchers and the public, as
suggested by one ethicist (EX05).
Any guidance would have to be future-proofed. One
principal researcher was concerned that guidelines could
become prescriptive in terms of setting out “you can do
this and you can’t do this”, rather than providing “guid-
ance for things that need to be considered” (EX02). They
went on:
It would be a mistake to set in place things now
which would limit the opportunities for innovative
research to happen, I guess the experience with
research in general makes me slightly cautious about
that. [EX02].
Discussion
The findings of this study showed strong support among
participants for the principles of biomedical ethics, but
also highlighted the ongoing challenges that ambulance
based researchers face in operationalising these in the
prehospital setting. Research in this relatively new set-
ting is likely to expand, as the need for early and effect-
ive healthcare interventions delivered by ambulance
clinicians is increasingly prioritised [4]. Both the litera-
ture and our findings suggest that, whilst the ambulance
setting offers unique opportunities for research, there
are specific ethical challenges to be met.
Capacity (both mental and physical) and the ability to
gain informed consent were highlighted as problematic
in this setting. Participants spoke about patient stress
and pain and time limitations in the emergency context,
with several stating that consent given in these circum-
stances may not be meaningful. Whilst these factors may
not be unique to the ambulance setting, they are com-
pounded by the nature of a prehospital emergency call,
where paramedics often work alone or in pairs and are
pressured to complete a call quickly so that they can
move on to the next call. This means that using ac-
cepted methods of enrolling patients on to trials is diffi-
cult. Related to this is the need to communicate
complex information regarding a trial in a short space of
time, raising concerns regarding the retention of infor-
mation by distressed patients and relatives. This is
reflected in the literature, where similar issues have been
discussed [13]. It may be necessary to develop strategies
to mitigate these concerns when enrolling patients into
trials.
Most interviews included discussions regarding the
use of legal representatives and consultees as surrogates
for patients who lack capacity, often referred to by the
participants as proxy consent. This in turn led to discus-
sions regarding whether a paramedic can act as an inde-
pendent legal representative for trials of medicinal
products under the MHU-CT, as in the ambulance set-
ting all paramedics on scene would be directly involved
in patient care, and therefore could not be seen as inde-
pendent of the trial where part of the care constituted
the intervention. The same question does not apply to
other types of ambulance based research, as the MCA
determines that a consultee who can advise the re-
searcher on the patient’s wishes with regards to partici-
pation in research must be sought. As this assumes that
the patient will be well known to the consultee, a para-
medic could not fulfil the consultee role, as it is unlikely
that they would have prior knowledge of the patient.
Alternative methods of gaining consent were also dis-
cussed, including waived or deferred consent and verbal
assent after a basic explanation of the intervention,
followed by later written consent to remain in the study.
Emergency waiver of consent is permitted under the UK
legislation where the treatment (both medicinal and
non-medicinal) is urgent and it is not practicable to seek
advice from a consultee (MCA) or a legal representative
(MHU-CT). Several of the expert informants considered
assent a workable option for ambulance based research.
Similarly, in an interview study with UK patients, most
participants thought this a viable method (albeit in the
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form of an abridged information sheet), provided they
would receive further information later on [15]. One
consent model that garnered particular debate was the
use of an advance opt-out system, similar to that re-
quired by some institutional review boards (ethics com-
mittees) in the US [29]. The reverse – that is prospective
opt-in – can be equally problematic. Predicting the need
for emergency treatment is difficult and makes it chal-
lenging to recruit enough potential participants without
incurring huge costs in both time and money. The time-
critical nature of such an event also means it may not be
possible to verify that a person has prospectively con-
sented without unduly delaying treatment [18].
All participants discussed the need for training and
guidance for paramedics and researchers on the ethical
challenges of ambulance based trials, in particular where
patients are conscious but incapable of giving fully in-
formed consent. With regard to what needs to happen
for more paramedics to engage in research, the views
and experiences of both principal researchers and para-
medics largely corresponded with existing literature.
First, paramedics will need assurances that research will
not adversely delay treatment or access to hospital for
patients [26]. Second, research will need to be seen as a
core responsibility of the paramedic role, rather than a
voluntary add-on [4, 26]. Third, paramedics will need to
be included in the research development process, thus
reinforcing their professional identities and acknowledg-
ing their expertise [6]. There were similar correlations
between the experiences of the UK-based prehospital re-
searchers interviewed and those of their counterparts in
the US, in terms of receiving inconsistent or unhelpful
decisions from ethics committees [30]. As with para-
medics, engaging with ethics committees from the out-
set, as well as specialised training on prehospital
research for committee members, could help to resolve
these issues [7, 10, 16]. Prehospital researchers in the
UK had, in general, had more positive experiences of
public consultation than those in the US, however.
Whereas both smaller PPI-type sessions and larger
meetings were considered useful by UK-based principal
researchers, only the former have proved worthwhile in
the US [10, 30]. Finally, whilst current legislation and
regulations do allow for the development of models of
enrolment and consent appropriate to ambulance based
trials, many participants felt these were not well under-
stood. All participants highlighted the need for better
guidance on the application of the legislation specific to
ambulance based research.
Strengths and limitations
This interview study offers a unique insight into the eth-
ical challenges of undertaking research in a developing
field, the ambulance service. The snowball sampling
method was chosen as it was felt this would be the best
way to gain buy-in from potential participants in what is
a relatively small field. It is important to acknowledge
the limitations of this method, which can included pos-
sible selection bias [31]. However, it was felt that the ad-
vantages of this methods outweighed these potential
disadvantages. By interviewing experienced researchers
and ethicists we were able to identify areas for concern.
Due to the time constraints of the project, this initial
study interviewed mainly UK based experts, which lim-
ited the analysis to UK regulations and research. We also
restricted participation to those who were currently ac-
tive in, or who had a stated interest in, ambulance based
research. It may have been useful to have included para-
medics and research ethics committee members not cur-
rently engaged in or with prehospital research, as well as
patient representatives, to get alternative perspectives,
but time constraints did not allow for this.
Implications for further research
Our research poses a number of questions regarding the
processes of assessing capacity and gaining consent for
research in the ambulance setting that require further
investigation to produce recommendations or guidelines
that are specific to ambulance based research. These
have implications for ambulance staff, services, re-
searchers and ethics committees who need to consider
and assess these issues. Future research will seek to gain
the opinions of ethics committee members, as well as a
wider group of ambulance service staff, patients and
their relatives, and researchers, in order to produce
training and guidance that is specific and relevant to am-
bulance based research.
Conclusion
This interview study of expert informants offers insight
into the challenges of undertaking research in the ambu-
lance setting. This is a major area of growth in clinical
research exploring the potential for early intervention
and alternative healthcare pathways, in order to improve
patient outcomes and reduce costs. We found that there
was general consensus among participants about where
these challenges lie. Whilst there were different opinions
on assessment of capacity and viable consent proce-
dures, participants largely agreed that the production of
ethical training and guidance specific to ambulance
based research would help researchers, paramedics and
ethics committees to navigate these challenges.
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